|
Code
|
5075E
|
|
MA number
|
EU/1/23/1766/003
|
|
Product Form:
|
sol inj 1x1,4 ml/420 µg (pero napl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU Orphan
|
|
MAH, country:
|
Ascendis Pharma Bone Diseases A/S, Denmark
|
|
Therapeutic Class:
|
56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU)
|
|
ATC:
|
| H |
SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| H05 |
CALCIUM HOMEOSTASIS |
| H05A |
PARATHYROID HORMONES AND ANALOGUES |
| H05AA |
Parathyroid hormones and analogues |
| H05AA05 |
Palopegteriparatide |
|
|
Shelf life:
|
36 |
|
Container:
|
pre-filled pen
|
|
Route of admin.:
|
Subcutaneous use
|
European Medicines Agency's database
